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Abstract
Subthalamic local field potentials in the beta band are considered as potential biomarkers for closed-loop deep brain stimulation.
To investigate the subthalamic beta band peak amplitudes in a Parkinson’s disease patient over an extended period of time by
using a novel and commercially available neurostimulator with permanent sensing capability. We recorded local field potentials
of the subthalamic nucleus using the Medtronic Percept™ implantable neurostimulator at rest and during physical activity (gait)
with and in response to deep brain stimulation. We found a double-peaked beta activity on both sides. Increasing stimulation and
physical activity resulted in a decreased beta band amplitude, but was accompanied by the appearance of a second, and previously
unrecognized peak at 13 Hz in the right hemisphere. Our results will support the investigation of distinct different peaks in the
beta band and their relevance and usefulness as closed-loop biomarkers.
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Introduction
Subthalamic nucleus (STN) local field potentials (LFPs)
represent an electrophysiological correlate of a patient’s
clinical symptoms in Parkinson’s disease (PD) [5].
Previous research has particularly investigated the beta
band (13–30 Hz) of LFPs, since peaks in this frequency
spectrum correlate with bradykinesia and respond to treat-
ment with L-Dopa and deep brain stimulation (DBS) [2, 4,
5]. Previous DBS devices did not allow for long-term
recording, making it difficult to measure LFPs over an
extended period of time. Here, we recorded continuous
LFPs from the implantable pulse generator (IPG;
Medtronic Percept™) in a PD patient and found that this
particular patient exhibited two distinct peaks in the beta-
band LFP power on either side. These peaks were record-
ed during intraoperative recordings as well as chronically
with the implantable device and were suppressed by stim-
ulation and gait, whereas a third peak on the right side
emerged only in response to stimulation.
Material and methods
The present data were obtained from a 56-year-old man
who had suffered from PD of the equivalence type for the
past 6 years. One year prior to surgery, he developed
severe on-off fluctuations. He never experienced falls,
gait-freezing, or signs of cognitive decline. In order to
ameliorate his symptoms, he underwent DBS surgery in
January 2020. Electrode leads (Medtronic 3389™) were
implanted into the dorsolateral aspect of the STN on both
sides. Single cell activity and LFPs were recorded during
the surgery and test stimulation was applied to evaluate its
effect on rigidity and bradykinesia. The pulse generator
was implanted on the 3rd postoperative day (Medtronic
Percept™) and stimulation initiated and optimized in the
following 8 weeks. Within the scope of the present work,
LFP traces were recorded from the electrodes adjacent to
the respective stimulation electrode on each side during
rest and gait (left STN: stimulation at contact #1, sensing
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at contacts #0 and #2; right STN: stimulation at contact
#10, sensing at contacts #9 and #11). Gait performance
was continuously monitored with sensors attached to the
shanks, thighs, arms, and chest, and step length, cadence,
and foot clearing were measured as described [1]. Gait
recordings and LFPs were synchronized by detecting the
impulses of a transcutaneous electric nerve stimulator trig-
gered by the gait recording devices. The exact timing and
amplitude of stimulation was recorded by the stimulator
and transferred to the tablet computer. All tests were ap-
proved by the local ethics committee (Project No.: 17-
639) and were in accordance with the declaration of
Fig. 1 a, b Frequency spectrogram at the beginning (at 0 min, green,
stim-off) and the end (at 15 min, red, stim-on) of the recording. Note
the appearance of a low-frequency 13-Hz peak in response to stimulation
on the right electrode (asterisk). c, d Peak amplitude at 15 Hz (P1, green)
and 25 Hz (P2, red) over time computed off-line by Matlab. Stimulation
has been stopped at t = 10 min (dashed vertical line). Note that the beta
amplitude on the right side (P1, green line) shows no lasting decrement in
response to stimulation onset due to the presence of a novel 13-Hz peak.
e, f Peak amplitude measured between 20 and 30 Hz over time as com-
puted in real time by the neurostimulator. Because of the high-frequency
spectrum, the appearance of the low beta peak at 13 Hz has no effect. g, h
Frequency spectra during stim-off and in response to gradual increase of
the stimulation amplitude until a clinically efficient stimulation threshold
was reached (1.4 mA, 130 Hz, 60 μs). Recordings from the left electrode
showed a gradual peak amplitude reduction with increasing stimulation.
On the right side, only the peak at 25 Hz decreased in response to stim-
ulation, whereas the peak at 15 Hz was replaced by a peak at 13 Hz when
stimulation was increased from 0.8 to 1.2 mA. Stimulation was increased
every 2min (0 mA, 0.3mA, 0.6 mA, 0.8mA, 1.2 mA, 1.4mA). Electrode
configuration is indicated above each image: zero-two left = stim at con-
tact #1, sensing from contact #0 and 2, left hemisphere; one three right =
stim at contact #2, sensing from contact #1 and 3, right hemisphere
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Helsinki. UPDRS III scores were obtained preoperatively
and postoperatively. During the tests, the raw LPSs (one
channel from each electrode lead) were gained up by
250× and streamed wirelessly to a tablet computer. The
sampling rate was 250 Hz. Further details of the recording
technique are described elsewhere [8]. The stimulator
computes the spectrum of the LFPs every 500 ms and
evaluates peak amplitudes in a user-defined frequency
band (here: 20–30 Hz). This peak amplitude evaluation
is performed by an on-chip digital fast Fourier transform
circuit. Amplitude information is reported in user-defined
center frequency ± 2.5 Hz. These data were also real time
streamed wirelessly to the tablet computer. Further evalu-
ation was done with Matlab: LFP spectra were computed
for 512 data points with an overlap of 256 points and
averaged to obtain spectra for epochs of 5 s. Peak ampli-
tudes for each of these 5 s-segments were measured as the
maximum of the spectrum in the range of 12–20 Hz (low
beta band) and 20–30 Hz (high beta band).
Results
LFPs recorded intraoperatively showed one peak ampli-
tude in the beta band on the left side and two distinct peak
amplitudes on the right side (Supp. Fig. 1a, b). Once the
IPG was implanted and its settings were optimized, stimu-
lation led to a remarkable improvement of the patient’s
symptoms (UPDRS III stim off: 38, med-on: 16, stim-on
and med-off: 7). The spectra of the LFP showed a double-
peaked beta activity on both sides (at 15 and 25 Hz)
(Fig. 1a, b; red trace), which was suppressed by stimulation
on the left side, whereas on the right side, a novel peak
appeared in the low beta band in response to stimulation
(asterisk) (Fig. 1a, b; green trace). The DBS effect was
readily appreciated when the individual peaks (15 Hz and
25 Hz) were analyzed separately over time (Fig. 1c, d), but
was not found in a compound analysis done by the stimu-
lator that computes the beta peak amplitude between 20
and 30 Hz (Fig. 1e, f). When we analyzed the LFP peaks
Fig. 2 a, b Schematic illustrating the test sequence. The patient was
subsequently asked to stand for 1 min and then walk for 300 m.
Stimulation was turned off after 1-min walking. Next, the patient was
asked to stand for another 1 min and then walk again for 300 m, during
which the stimulation was switched on wirelessly after 1 min. c–f
Frequency spectrograms obtained during the respective gait and stimula-
tion period. Each part of the test was reproduced once and the results
represented as duplicates. The colors of the different curves correspond
to the respective periods in a and b. Note the differences between the
spectra of the left (c, d) and right (e, f) electrode. Electrode configuration
is indicated above each image: zero-two left = stim at contact #1, sensing
from contact #0 and 2, left hemisphere; one three right = stim at contact
#2, sensing from contact #1 and 3, right hemisphere
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in response to different stimulation amplitudes, we found a
gradual reduction of both beta peaks on the left side with
increasing stimulation amplitudes (Fig. 1g). Conversely,
on the right side, this was only true for the peak at
25 Hz, whereas the low beta peak at 15 Hz was replaced
by a peak at 13 Hz when stimulation was increased from
0.6 to 0.8 mA (Fig. 1h). In addition to these experiments,
we tested the effect of gait on LFPs in the same patient
(Fig. 2). The LFP spectra recorded during gait were eval-
uated in three distinct intervals: standing (with/without
stim), walking (stim on), and walking (stim off) (Fig.
2a, b). On the left side, stimulation caused a complete sup-
pression of beta peaks; gait suppressed beta peaks almost
completely when stimulation was off (Fig. 2c, d).
However, on the right side, stimulation caused only a par-
tial suppression of beta peaks as well as the appearance of
an additional peak at 13 Hz. Gait had an additional but
incomplete suppressive effect on beta peaks on the right
side during gait under stimulation (Fig. 2e, f).
Discussion
This single case study illustrates the prospects of using novel
neurostimulation devices that allow continuous recording of
LFPs in addition to delivering DBS to the respective target
structure. As compared with previous studies that recorded
beta peaks in PD patients temporally, our results suggest a
more complex behavior of these beta peaks in response to
DBS and to gait. In this regard, several aspects merit partic-
ular consideration: first, two beta peaks were seen on either
side and behaved similarly with respect to stimulation and
movement on the left side, i.e., showed an almost complete
disappearance. However, on the right side, only the high
beta peak reacted with a moderate amplitude reduction to
both gait and stimulation, whereas the low beta peak disap-
peared with higher stimulation and was replaced by a 13-Hz
peak, which has not been described previously. Numerous
previous studies have not described low and high beta
peaks, thus possibly neglecting the presence of two distinct
peaks in this part of the spectrum. In the literature, there is
still limited evidence for a different behavior of low and
high beta peaks: low beta peaks were associated with freez-
ing of gait [7, 9] and react differently to dopaminergic treat-
ment [6]. In our study, movement (gait) suppressed beta
peaks on the left side almost completely but caused only a
partial amplitude decrease of beta activity on the right side.
These observations have important implications for LFP-
controlled closed-loop stimulation and future studies need
to address the specific beta peaks and their behavior in re-
sponse to DBS. In a recent paper, beta characteristics of
motor subtypes (tremor dominant, gait-related) were de-
scribed [10]. The identification of these unique
electrophysiological “fingerprints” and their connection to
motor subtypes will likely support the investigation of
LFPs for closed-loop stimulation. For instance, when move-
ment causes a suppression of beta peaks as seen in our
recordings of the left lead, this may erroneously be
interpreted as absence of bradykinesia by the algorithm [3].
When stimulation results in an additional peak, as seen in
our recordings (Fig. 2) of the right lead, this may likewise
affect the usefulness of LFPs as a feedback signal for
closed-loop stimulation.
Conclusions
In summary, our results will support the investigation of
patient-specific individual LFP patterns (LFP “fingerprints”)
and aid the development of LFP-based feedback signals. In
addition, our exploratory study highlights the potential of dual
deep brain stimulation and recording devices (DBS/R) for the
study of LFPs.
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